Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ECOR electroCore	$5.06 -2.9%	$6.10	$4.16 ▼ $19.49	$38.35M	0.27	132,406 shs	70,608 shs
NMTC NeuroOne Medical Technologies	$0.78 +3.8%	$0.76	$0.40 ▼ $1.39	$39M	0.68	270,856 shs	209,399 shs
OSRH OSR	$0.48 -5.3%	$1.05	$0.45 ▼ $13.40	$10.25M	1.49	2.03 million shs	218,566 shs
RBOT Vicarious Surgical	$6.53 +10.7%	$8.64	$5.00 ▼ $19.00	$38.72M	1.41	30,216 shs	22,851 shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ECOR electroCore	+4.83%	+1.36%	-26.62%	+3.78%	-14.45%
NMTC NeuroOne Medical Technologies	-6.98%	-12.62%	-16.52%	+21.96%	-9.22%
OSRH OSR	-5.45%	-10.64%	-53.57%	-58.56%	+50,139,900.00%
RBOT Vicarious Surgical	-7.93%	-25.25%	-43.02%	-14.14%	-6.03%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ECOR electroCore	2.6098 of 5 stars	3.5	2.0	0.0	0.0	2.0	2.5	0.6
NMTC NeuroOne Medical Technologies	2.8929 of 5 stars	3.5	5.0	0.0	0.0	3.0	0.8	0.0
OSRH OSR	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
RBOT Vicarious Surgical	1.6068 of 5 stars	2.0	2.0	0.0	0.0	3.0	2.5	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ECOR electroCore	3.00	Buy	$25.50	403.95% Upside
NMTC NeuroOne Medical Technologies	3.00	Buy	$1.45	85.90% Upside
OSRH OSR	0.00	N/A	N/A	N/A
RBOT Vicarious Surgical	2.00	Hold	$7.00	7.20% Upside

Current Analyst Ratings Breakdown

Latest OSRH, NMTC, RBOT, and ECOR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
8/13/2025	RBOT Vicarious Surgical	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$8.50 ➝ $7.00

(Data available from 8/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ECOR electroCore	$25.18M	1.52	N/A	N/A	$0.15 per share	33.73
NMTC NeuroOne Medical Technologies	$3.45M	11.30	N/A	N/A	$0.16 per share	4.88
OSRH OSR	N/A	N/A	N/A	N/A	$6.45 per share	N/A
RBOT Vicarious Surgical	N/A	N/A	N/A	N/A	$3.89 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ECOR electroCore	-$11.89M	-$1.62	N/A	N/A	N/A	-47.84%	-221.93%	-69.17%	N/A
NMTC NeuroOne Medical Technologies	-$12.32M	-$0.15	N/A	∞	N/A	-55.44%	-163.49%	-78.67%	N/A
OSRH OSR	-$2.41M	N/A	0.00	∞	N/A	N/A	-12.19%	-8.18%	N/A
RBOT Vicarious Surgical	-$63.22M	-$10.09	N/A	N/A	N/A	N/A	-148.14%	-98.07%	N/A

Latest OSRH, NMTC, RBOT, and ECOR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2025	Q3 2025	NMTC NeuroOne Medical Technologies	-$0.05	-$0.03	+$0.02	-$0.03	$1.82 million	$1.70 million
8/14/2025	Q2 2025	OSRH OSR	N/A	$0.02	N/A	$0.02	N/A	$1.14 million
8/12/2025	Q2 2025	RBOT Vicarious Surgical	-$2.61	-$2.23	+$0.38	-$2.23	N/A	N/A
8/6/2025	Q2 2025	ECOR electroCore	-$0.32	-$0.35	-$0.03	-$0.44	$7.24 million	$7.38 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ECOR electroCore	N/A	N/A	N/A	N/A	N/A
NMTC NeuroOne Medical Technologies	N/A	N/A	N/A	N/A	N/A
OSRH OSR	N/A	N/A	N/A	N/A	N/A
RBOT Vicarious Surgical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ECOR electroCore	N/A	1.10	0.95
NMTC NeuroOne Medical Technologies	N/A	7.13	1.09
OSRH OSR	N/A	0.18	0.20
RBOT Vicarious Surgical	N/A	5.11	5.11

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ECOR electroCore	26.74%
NMTC NeuroOne Medical Technologies	16.07%
OSRH OSR	55.30%
RBOT Vicarious Surgical	47.27%

Insider Ownership

Company	Insider Ownership
ECOR electroCore	13.80%
NMTC NeuroOne Medical Technologies	8.90%
OSRH OSR	33.67%
RBOT Vicarious Surgical	11.99%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ECOR electroCore	50	7.58 million	6.54 million	Not Optionable
NMTC NeuroOne Medical Technologies	20	50.00 million	45.55 million	Optionable
OSRH OSR	N/A	21.58 million	14.32 million	N/A
RBOT Vicarious Surgical	210	5.93 million	5.22 million	No Data

OSRH, NMTC, RBOT, and ECOR Headlines

Recent News About These Companies

Robotic surgery heats up with clearances and clinical trials

August 20 at 12:12 AM | crainsnewyork.comC

Vicarious Surgical (NYSE:RBOT) Given New $7.00 Price Target at Piper Sandler

August 15, 2025 | marketbeat.com

Vicarious Surgical (NYSE:RBOT) Announces Quarterly Earnings Results, Beats Expectations By $0.38 EPS

August 14, 2025 | marketbeat.com

Vicarious Surgical delays robot clinical timeline

August 14, 2025 | finance.yahoo.com

Vicarious Surgical’s Earnings Call: Progress Amid Challenges

August 14, 2025 | msn.com

Vicarious Surgical’s new CEO pushes back robot development timeline

August 14, 2025 | fiercebiotech.comF

Vicarious Surgical delays robot timeline

August 14, 2025 | finance.yahoo.com

Piper Sandler Cuts Vicarious Surgical (NYSE:RBOT) Price Target to $7.00

August 14, 2025 | americanbankingnews.com

Vicarious Surgical pushes back surgical robot timeline again

August 13, 2025 | massdevice.com

Vicarious Surgical Inc. (NYSE:RBOT) Q2 2025 Earnings Call Transcript

August 13, 2025 | msn.com

Vicarious Surgical Reports Improved Q2 Financials and Leadership Change

August 13, 2025 | msn.com

Vicarious Surgical Inc. (RBOT) Q2 2025 Earnings Call Transcript

August 12, 2025 | seekingalpha.com

Vicarious Surgical anticipates FY25 cash burn of about $50M

August 12, 2025 | msn.com

Vicarious Surgical reports Q2 EPS ($2.23), consensus ($2.50)

August 12, 2025 | msn.com

Vicarious Surgical Reports Second Quarter 2025 Financial Results

August 12, 2025 | businesswire.com

Vicarious Surgical (RBOT) to Release Earnings on Tuesday

August 11, 2025 | americanbankingnews.com

Vicarious Surgical (NYSE:RBOT) Stock Price Down 4.4% - What's Next?

August 8, 2025 | marketbeat.com

Vicarious Surgical (RBOT) to Release Quarterly Earnings on Tuesday

August 6, 2025 | marketbeat.com

Vicarious Surgical names Stephen From as next CEO

August 2, 2025 | medtechdive.comM

Vicarious Surgical Announces Leadership Transition: Stephen From, Healthcare Industry Veteran, Appointed Chief Executive Officer

July 31, 2025 | finance.yahoo.com

Vicarious Surgical has a new CEO

July 31, 2025 | massdevice.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

OSRH, NMTC, RBOT, and ECOR Company Descriptions

electroCore NASDAQ:ECOR

$5.06 -0.15 (-2.88%)

As of 02:56 PM Eastern

electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

NeuroOne Medical Technologies NASDAQ:NMTC

$0.78 +0.03 (+3.82%)

As of 02:44 PM Eastern

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.

OSR NASDAQ:OSRH

$0.48 -0.03 (-5.27%)

As of 02:37 PM Eastern

OSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D "platform technologies" versus "assets only" companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea.

Vicarious Surgical NYSE:RBOT

$6.53 +0.63 (+10.68%)

As of 02:55 PM Eastern

Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time